£97.93

New Angiogenesis Research (Nova Biomedical)

General Medical Issues

Price data last checked 95 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£98 today · usual range £0–£0 · best ever £85

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 636 days • 636 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 636 days • 4 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £92-99 (417 days, 65.6%)

Price range: £85 - £119

Price levels: 4 price ranges over 636 days

Description

Angiogenesis -- the growth of new blood vessels -- is an important natural process occurring in the body, both for health and as related to disease. Angiogenesis occurs in the healthy body to help heal wounds and to help restore blood flow to tissues after injury or insult. In females, Angiogenesis also occurs during the monthly reproductive cycle (to rebuild the uterus lining, to mature the egg during ovulation) and during pregnancy (to build the placenta, the circulation between mother and foetus). The healthy body controls Angiogenesis through a series of 'on' and 'off' switches. The main 'on' switches are known as Angiogenesis-stimulating growth factors. The main 'off' switches are known as Angiogenesis inhibitors. When angiogenic growth factors are produced in excess of angiogenesis inhibitors the balance is tipped in favour of blood vessel growth. When inhibitors are present in excess of stimulators, angiogenesis is stopped. The normal, healthy body maintains a perfect balance of angiogenesis modulators. In general, angiogenesis is 'turned off' by the production of more inhibitors than stimulators. Tumour angiogenesis is the proliferation of a network of blood vessels that penetrates into cancerous growths, supplying nutrients and oxygen and removing waste products. Tumour angiogenesis actually starts with cancerous tumour cells releasing molecules that send signals to surrounding normal host tissue. This signalling activates certain genes in the host tissue that, in turn, cause proteins to encourage growth of new blood vessels. This new book examines its angiogenesis within the context of theory and its applications to cancer treatment.

Product Specifications

Format: hardcover
ASIN: 1594542392
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 29 June 2005
Listed Since: 27 December 2006

Barcode

No barcode data available

New Angiogenesis Research (Nova Biomedical)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

New Research on Angiogenesis Inhibitors - Nova Science Pub Inc

Angiogenesis Inhibition: 180 (Recent Results in Cancer Research, 180)

Angiogenesis in Health, Disease and Malignancy

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Angiogenesis in Health, Disease and Malignancy

Angiogenesis: Molecular Biology, Clinical Aspects: 263 (NATO Science Series A:, 263)

Angiogenesis: Biology and Pathology (Cold Spring Harbor Perspectives in Medicine)

Vascular Development: 283 (Novartis Foundation Symposia)

Molecular, Cellular, and Clinical Aspects of Angiogenesis: 285 (NATO Science Series A:, 285)

Anti-Angiogenesis Drug Discovery and Development: Volume 2

Angiogenesis Protocols: 467 (Methods in Molecular Biology, 467)

A History of Angiogenesis: Discoveries, Research and the Therapeutic Potential (BASIC AND CLINICAL ANGIOGENESIS)

Mechanical and Chemical Signaling in Angiogenesis: 12 (Studies in Mechanobiology, Tissue Engineering and Biomaterials, 12)

Mechanical and Chemical Signaling in Angiogenesis: 12 (Studies in Mechanobiology, Tissue Engineering and Biomaterials, 12)

Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease

Angiogenesis: In Vitro Systems: 443 (Methods in Enzymology): Volume 443

Angiogenesis: An Integrative Approach from Science to Medicine

Angiogenesis Protocols: 1430 (Methods in Molecular Biology, 1430)

Modeling Tumor Vasculature: Molecular, Cellular, and Tissue Level Aspects and Implications

Angiogenesis: From Basic Science to Clinical Applications

Inflammation and Angiogenesis

Angiogenesis: Methods and Protocols: 2441 (Methods in Molecular Biology, 2441)

Angiogenesis: Pt. A: In Vivo Systems: In Vivo Systems Pt. A (Methods in Enzymology): Volume 444